Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 329, pseudogene (RN7SL329P)

Target
RN7SL329P
Molecular classification
Other (Pseudogene, non-coding RNA pseudogene)
01

Overview

**RNA, 7SL, cytoplasmic 329, pseudogene (RN7SL329P)** is a human genomic locus classified as a processed pseudogene of the 7SL RNA component. The 7SL RNA is a non-coding RNA serving as a critical part of the signal recognition particle (SRP), which is responsible for targeting secretory proteins to the endoplasmic reticulum. However, as a pseudogene, RN7SL329P does not produce a functional 7SL RNA and is considered non-coding. Most 7SL pseudogenes are truncated and nonfunctional, thought to arise via retrotransposition events[1][3]. While some transcribed pseudogenes may function as competitive endogenous RNAs ("miRNA sponges") or participate in other subtle regulatory mechanisms, there is no current evidence of RN7SL329P acting as a therapeutic target, being involved in disease, interacting with drugs, or serving as a biomarker[1][2][3]. It is primarily of genomic or evolutionary interest, highlighting retrotranspositional processes and the complexity of non-coding elements in the human genome.

Other names
RN7SL329P7SL RNA pseudogene 3297SL cytoplasmic RNA pseudogene 329
02

Biological functions

Other (No established biological function; typical pseudogene role may involve acting as a non-coding RNA or possible miRNA sponge, but not well characterized for this specific pseudogene[2][3])
03

Disease associations

Other (No direct disease role established for RN7SL329P; parental functional RNA (7SL) has broader importance but the pseudogene itself is not implicated in disease[1][3])

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 329, pseudogene (RN7SL329P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 329, pseudogene (RN7SL329P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call